0
October 13, 2004, Vol 292, No. 14 >
From the Centers for Disease Control and Prevention | October 13, 2004

Availability of Revised Guidelines for Identifying and Managing Jaundice in Newborns FREE

JAMA. 2004;292(14):1678. doi:10.1001/jama.292.14.1678.
Text Size: A A A
Published online
Article
References

AVAILABILITY OF REVISED GUIDELINES FOR IDENTIFYING AND MANAGING JAUNDICE IN NEWBORNS

MMWR. 2004;53:590-591

The American Academy of Pediatrics has published revised guidelines for identifying and managing jaundice in newborns. Jaundice is caused by an increase in serum bilirubin concentration (i.e., hyperbilirubemia)1 and makes the skin appear yellow. Excessive hyperbilirubinemia can lead to permanent brain damage (i.e., kernicterus).1 The revised guidelines were developed to promote greater uniformity and consistency of care for all newborns. Four key recommendations were emphasized for physicians:

  • Perform a systematic assessment of all infants before their discharge from the birth hospital. This assessment will determine their risk for severe jaundice and can be performed by measuring the total serum bilirubin or transcutaneous bilirubin levels, or assessing risk factors, or both.2

  • Provide appropriate follow-up based on the time of discharge. A follow-up visit should be scheduled within 3-5 days of an infant’s birth, when the bilirubin level is likely to be highest.

  • Promote and support successful breastfeeding practices. Encourage breastfeeding at least 8-12 times a day in the first days of an infant’s life. Effective breastfeeding can reduce substantially the risk for hyperbilirubinemia.

  • Provide parents with written and oral information about the risks associated with jaundice in newborns. Information about jaundice in newborns is available at http://www.aap.org/family/jaundicefaq.htm.

CDC supports the use of these guidelines for eliminating kernicterus and hyperbilirubinemia. In 2001, CDC reported an increase of kernicterus cases in the United States2 and encouraged systematic assessment of bilirubin levels in newborns before their discharge from the birth hospital, along with proper follow-up care, lactation support, and parent education about jaundice. Additional information about kernicterus is available at http://www.cdc.gov/ncbddd/dd/kernicterus.htm. Information about the revised guidelines is available at http://aappolicy.aappublications.org/cgi/content/abstract/pediatrics;114/1/297.
REFERENCES
1 +
American Academy of Pediatrics.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.  Pediatrics. 2004;114297-316
PubMed   |  Link to Article
2 +
CDC.  Kernicterus in full-term infants—United States, 1994-1998.  MMWR. 2001;50491

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

1 +
American Academy of Pediatrics.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.  Pediatrics. 2004;114297-316
PubMed   |  Link to Article
2 +
CDC.  Kernicterus in full-term infants—United States, 1994-1998.  MMWR. 2001;50491

Letters

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Neonatal Trial Criticized for Inadequate Consent
JAMA. 2013;309(20):2087. doi:10.1001/jama.2013.5928.
CDC Releases First National Guidelines on Managing Q Fever
JAMA. 2013;309(18):1887. doi:10.1001/jama.2013.4647.
Related Topics
PubMed Articles
[Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
Ginekol Pol 2012;;83(9):713-7.
Clinical research informing neonatal care at the University Hospital of the West Indies: 50 years experience.
West Indian Med J 2012;;61(4):351-5.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems